Gerald Heinz Möller
Founder at AdrenoMed AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Charles Dadswell | M | 65 | 11 years | |
| Bernd Wegener | M | 76 |
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | 15 years |
| Marc Cluzel | M | 69 | 12 years | |
| Simona Piccirella | M | - |
Diadem SpA
 Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | - |
| Wolfgang Kintzel | M | 57 |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | 9 years |
| Andreas Schmidt | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | 14 years |
| Andreas Bergmann | M | 63 |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | 15 years |
| Rodney Weldon Turner | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Robert Epstein | M | 69 | 12 years | |
| Julia Neugebauer | M | - | 18 years | |
| Apollon Papadimitriou | M | - |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 7 years |
| Krisja Vermeylen | F | 62 | 7 years | |
| Philipp Beckhove | M | - |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 8 years |
| Dieter Trau | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | 14 years |
| Rainer Kramer | M | 60 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 9 years |
| Paul Kinnon | M | 61 |
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | 4 years |
| Henrijette Richter | M | 53 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | - |
| Patrick Baeuerle | M | 66 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 8 years |
| Priyanka Belawat | M | 45 |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | - |
| Regina Hodits | M | 54 |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Ann Merchant | F | 59 | 6 years | |
| Reinhard Niessner | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Lukas Günther | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Markus Hosang | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Michael Brosnan | M | 69 | 6 years | |
| Rainer Christine | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Rainer Strohmenger | M | 57 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 4 years |
| Richard Jones | M | 51 |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | 2 years |
| Markus Zumbansen | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Metod Miklus | M | 65 |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | - |
| George Golumbeski | M | 67 | 6 years | |
| Ralf Ostendorp | M | - | 25 years | |
| Klaus de Wall | M | - | 19 years | |
| Aristotelis Nastos | M | 56 |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | 13 years |
| Charlotte Lohmann | F | 54 | 12 years | |
| Michael Burgess | M | 61 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 2 years |
| Francesco Granata | M | 73 |
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | - |
| Diana Saraceni | F | 52 |
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | - |
| Antonio Boniolo | M | 73 |
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | - |
| Karlheinz Schmelig | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Matthias Kromayer | M | 58 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 2 years |
| Scott Ericksen | M | 52 | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marc Stapley | M | 54 | 7 years | |
| Francis deSouza | M | 53 | 10 years | |
| Markus Enzelberger | M | 55 | 18 years | |
| Anke Linnartz | F | 54 | - | |
| Malte Peters | M | 61 | 5 years | |
| Claudia Gutjahr-Löser | M | - | - | |
| Frank Morich | M | 69 | 5 years | |
| Ludger Langer | M | - | - | |
| Klaus Kühn | M | 72 | 3 years | |
| Robert Kelley | M | 52 | 7 years | |
| Kevin Williams | M | - | - | |
| Alexandra Goller | F | - | - | |
| Paul E. Otth | M | 80 |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | 14 years |
| Nicholas Naclerio | M | 62 | 6 years | |
| Siegmund Karasch | M | 59 |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | - |
| Wendy Johnson | F | 72 | 7 years | |
| Jürgen Drews | M | 91 | 14 years | |
| Daniel Camus | M | 70 | 12 years | |
| Paul Grint | M | 66 | 8 years | |
| Geoffrey Nicholas Vernon | M | 72 | 16 years | |
| Andreas Plückthun | M | 65 | 15 years | |
| Metin Colpan | M | 69 | 8 years | |
| Walter Blättler | M | 75 | 8 years | |
| Dalen Meeter | M | 46 | 9 years | |
| Karin Eastham | F | 74 | 5 years | |
| Matthew Posard | M | 56 | 9 years | |
| Christian G. Cabou | M | 74 | 7 years | |
| Robert Friesen | M | 60 | 3 years | |
| AmirAli Talasaz | M | 44 | 1 years | |
| Martin Clark | M | - | - | |
| Robert Ragusa | M | 64 | 8 years | |
| Nick Nelson | M | 41 | 10 years | |
| Samraat Raha | M | 52 | 4 years | |
| Wouter Meuleman | M | - | 4 years | |
| Gautam Kollu | M | 50 | 6 years | |
| Amin Ronaghi | M | - | 3 years | |
| Stephane Mouradian | M | - | 6 years | |
| Timothy E. Cloutier | M | 50 | 3 years | |
| Brent Vetter | M | 40 | 2 years | |
| Helmy Eltoukhy | M | 45 | 4 years | |
| Subra Sankar | M | 64 | 6 years | |
| Mya Thomae | F | - | 3 years | |
| B. Cimler | M | 66 | - | |
| Robert C. Kain | M | 63 | 15 years | |
| Peter Bettermann | M | 76 |
University of Kiel
| 3 years |
| Richard Klausner | M | 72 | 3 years | |
| Marlies Sproll | M | - | 17 years | |
| Laura Lauman | F | - | - | |
| Jeffrey Huber | M | 55 | 1 years | |
| Paul L. Bianchi | M | 61 | 4 years | |
| Tina Nova | M | 70 | 1 years | |
| Bradford Crutchfield | M | 62 | 1 years | |
| Jorge Velarde | M | 57 | 11 years | |
| Emily Winn-Deen | M | - | - | |
| Gabriele Elbl | M | 62 | 5 years | |
| Stephen Yoder | M | 48 | 11 years | |
| Daniel S. Grosu | M | - | - | |
| Brandon Poe | M | - | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 58 | 58.00% |
| United States | 37 | 37.00% |
| Italy | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gerald Heinz Möller
- Personal Network
